However, a moment after the reports were published and after it seemed that the CEO failed to “pull out a rabbit” that would squeeze returns, he suddenly “pulled out a rabbit” and even some will see it as a “rabbit” – Teva CEO Kar Schultz said that the Israeli pharmaceutical manufacturer To Corona to assist in the production of vaccine doses.
Schultz declined to say which nature companies he was talking to, saying no agreements had been signed yet. However, according to him, the company has facilities in Israel, Europe and the United States that can be converted to the production of vaccine doses.
Schultz’s statement managed to stop the declines in Wall Street in the stock and it began to correct. Schultz says in an interview with Bloomberg, who drowned, is currently the distributor of Corona vaccines in Israel (which is currently the head of the storage countries). According to him, the distribution of the vaccine in Israel “was a really fantastic experience with a very smooth operation.”
Teva will also be happy to help with distribution in the US through its subsidiary, Anda (the equivalent of its subsidiary SLA in Israel). this.
Schultz’s remarks are very impressive among investors because corona vaccine oils are still in limited supply around the world. Although various companies cooperate in their production, the Western world is in distress of scarcity, of which nature can be the solution.
So is nature the one who will save the world? Days will tell, but there is no doubt that the greatest quality production capacity in the world is in her hands and she can help if only they will give it to her.
Provident fund holdings in Teva shares
Holdings of pension funds in Teva shares
You would not believe which institutional institution returned to buy – and a lot
The Prime Minister’s visit to Teva together with the CEO of Teva Israel. Photo – Elad Malka.